臺大醫院-精神醫學部;臺大醫學院-精神科;HSIANG-YUAN LINLin, Hsiang-YuanHsiang-YuanLinLin, Chao-ChengChao-ChengLinCHEN-CHUNG LIULiu, Chen-ChungChen-ChungLiu2018-09-102018-09-102012http://www.scopus.com/inward/record.url?eid=2-s2.0-84870241726&partnerID=MN8TOARShttp://scholars.lib.ntu.edu.tw/handle/123456789/373302110 bytestext/html[SDGs]SDG3amfebutamone; aripiprazole; clonazepam; fluoxetine; propranolol; adult; anhedonia; case report; Diagnostic and Statistical Manual of Mental Disorders; dose response; drug dose increase; drug dose reduction; drug efficacy; drug safety; drug withdrawal; female; grief; guilt; human; hypertension; hypomania; impulsiveness; insomnia; letter; major depression; mood disorder; priority journal; recurrent disease; retreatment; side effect; sleep disorder; social status; suicidal ideation; thought disorder; treatment response; weight reduction; Bipolar Disorder; Clonazepam; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged; Piperazines; Quinolones; RecurrenceHypomania associated with adjunctive aripiprazole in an elder female with recurrent major depressive disorder: Dose-related phenomenon?journal article10.1097/JCP.0b013e318272d2b7